D-0337-2018 Class I Terminated

Recalled by AuroMedics Pharma LLC — East Windsor, NJ

FDA drug recall D-0337-2018 was initiated by AuroMedics Pharma LLC on December 20, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter; white particulate matter identified as mold was found in one bag The recall status is terminated (terminated June 24, 2019). Affected quantity: 9,050 bags.

Recall Details

Product Type
Drugs
Report Date
February 14, 2018
Initiation Date
December 20, 2017
Termination Date
June 24, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,050 bags

Product Description

Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51

Reason for Recall

Presence of Particulate Matter; white particulate matter identified as mold was found in one bag

Distribution Pattern

Product was distributed throughout United States.

Code Information

Lot # CLZ160007, Exp August 2018